Blue light-filtering intraocular lenses: Review of potential benefits and side effects

Journal of Cataract and Refractive Surgery

Volumn 35, Issue 7, 2009, Pages 1281-1297

  Cuthbertson, Fiona M ^a   Peirson, Stuart N ^a   Wulff, Katharina ^a   Foster, Russell G ^a   Downes, Susan M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLUE LIGHT; BLUE LIGHT FILTERING INTRAOCULAR LENS; CATARACT EXTRACTION; EYE PROTECTION; HUMAN; LENS IMPLANT; LIGHT EXPOSURE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION;

ANIMALS; CATARACT EXTRACTION; HUMANS; LENS IMPLANTATION, INTRAOCULAR; LENSES, INTRAOCULAR; LIGHT; OPTICS AND PHOTONICS; PROSTHESIS DESIGN; RADIATION INJURIES; RETINA; RETINAL DEGENERATION;

EID: 67649577219     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2009.04.017     Document Type: Article

References (224)

1. Advisory Group on Non-ionising Radiation. Health Effects From Ultraviolet Radiation (2002), National Radiological Protection Board, Oxford, UK. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947340456 Accessed April 16, 2009
2. Wittenberg S. Solar radiation and the eye: a review of knowledge relevant to eye care. Am J Optom Physiol Opt 63 (1986) 676-689
3. Lerman S. An experimental and clinical evaluation of lens transparency and aging. J Gerontol 38 (1983) 293-301. http://geronj.oxfordjournals.org/cgi/reprint/38/3/293 Accessed April 16, 2009
4. Bron A.J., Vrensen G.F.J.M., Koretz J., Maraini G., and Harding J.J. The ageing lens. Ophthalmologica 214 (2000) 86-104
5. Dillon J., Zheng L., Merriam J.C., and Gaillard E.R. Transmission spectra of light to the mammalian retina. Photochem Photobiol 71 (2000) 225-229
6. Gaillard E.R., Zheng L., Merriam J.C., and Dillon J. Age-related changes in the absorption characteristics of the primate lens. Invest Ophthalmol Vis Sci 41 (2000) 1454-1459. http://www.iovs.org/cgi/reprint/41/6/1454.pdf Accessed April 16, 2009
7. Weale R.A. Age and the transmittance of the human crystalline lens. J Physiol 395 (1988) 577-587. http://jp.physoc.org/cgi/reprint/395/1/577 Accessed April 16, 2009
8. Mellerio J. Yellowing of the human lens: nuclear and cortical contributions. Vision Res 27 (1987) 1581-1587
9. Dillon J., Zheng L., Merriam J.C., and Gaillard E.R. Transmission of light to the aging human retina: possible implications for age related macular degeneration. Exp Eye Res 79 (2004) 753-759
10. Davison J.A., and Patel A.S. Light normalizing intraocular lenses. Int Ophthalmol Clin 45 1 (2005) 55-106
11. Mäntyjärvi M., Syrjäkoski J., Tuppurainen K., and Honkonen V. Colour vision through intraocular lens. Acta Ophthalmol Scand 75 (1997) 166-169
12. Ichikawa K., Tamaoki A., and Ichikawa H. The color sense of pseudophakic eyes: chromatopsia. In: Ohta Y. (Ed). Color Vision Deficiencies; Proceedings of the Symposium of the International Research Group in Color Vision Deficiencies, Tokyo, Japan, March 26-28, 1990 (1990), Kugler & Ghedini, Amsterdam, The Netherlands 237-243
13. Noell W.K., Walker V.S., Kang B.S., and Berman S. Retinal damage by light in rats. Invest Ophthalmol 5 (1966) 450-473. http://www.iovs.org/cgi/reprint/5/5/450.pdf Accessed April 16, 2009
14. Ham Jr. W.T., Ruffolo Jr. J.J., Mueller H.A., Clarke A.M., and Moon M.E. Histologic analysis of photochemical lesions produced in rhesus retina by short-wavelength light. Invest Ophthalmol Vis Sci 17 (1978) 1029-1035. http://www.iovs.org/cgi/reprint/17/10/1029 Accessed April 16, 2009
15. Ham Jr. W.T., Mueller H.A., and Sliney D.H. Retinal sensitivity to damage from short wavelength light. Nature 260 (1976) 153-155
16. Ham Jr. W.T., Mueller H.A., Ruffolo Jr. J.J., and Clarke A.M. Sensitivity of the retina to radiation damage as a function of wavelength. Photochem Photobiol 29 (1979) 735-743
17. Ham Jr. W.T., Ruffolo Jr. J.J., Mueller H.A., and Guerry III D. The nature of retinal radiation damage: dependence on wavelength, power level and exposure time. Vision Res 20 (1980) 1105-1111
18. Algvere P.V., Marshall J., and Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 84 (2006) 4-15
19. Hao W., Wenzel A., Obin M.S., Chen C.-K., Brill E., Krasnoperova N.V., Eversole-Cire P., Kleyner Y., Taylor A., Simon M.I., Grimm C., Reme´ C.E., and Lem J. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet 32 (2002) 254-260
20. Mainster M.A., Ham Jr. W.T., and Delori F.C. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology 90 (1983) 927-931 discussion by T Lawwill, 931-932
21. Marshall J. The ageing retina: physiology or pathology. Eye 1 (1987) 282-295
22. Braunstein R.E., and Sparrow J.R. A blue-blocking intraocular lens should be used in cataract surgery. [controversies]. Arch Ophthalmol 123 (2005) 547-549
23. Boulton M., Ro´z˙anowska M., and Ro´z˙anowski B. Retinal photodamage. J Photochem Photobiol B 64 (2001) 144-161
24. Davies S., Elliott M.H., Floor E., Truscott T.G., Zareba M., Sarna T., Shamsi F.A., and Boulton M.E. Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic Biol Med 31 (2001) 256-265
25. Bürkle A. Mechanisms of ageing. Eye 15 (2001) 371-375
26. Barja G. Endogenous oxidative stress: relationship to aging, longevity and caloric restriction. Ageing Res Rev 1 (2002) 397-411
27. Liang F.-Q., and Godley B.F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76 (2003) 397-403
28. Winkler BS., Boulton ME., Gottsch JD., and Sternberg P. Oxidative damage and age-related macular degeneration. Available at:. http://www.molvis.org/molvis/v5/a32/ Accessed April 16, 2009
29. Mainster M.A. Intraocular lenses should block UV radiation and violet but not blue light. Arch Ophthalmol 123 (2005) 550-555
30. Beatty S., Koh H.-H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45 (2000) 115-134
31. Young R.W. Solar radiation and age-related macular degeneration. Surv Ophthalmol 32 (1988) 252-269
32. Patel J.I. Is cataract surgery a risk factor for progression of macular degeneration?. Curr Opin Ophthalmol 18 (2007) 9-12
33. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, and beta carotene, and zinc for age-related macular degeneration and vision loss; AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
34. Gottsch J.D., Bynoe L.A., Harlan J.B., Rencs E.V., and Green W.R. Light-induced deposits in Bruch's membrane of protoporphyric mice. Arch Ophthalmol 111 (1993) 126-129. http://archopht.ama-assn.org/cgi/reprint/111/1/126 Accessed April 16, 2009
35. Noell W.K. Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision Res 20 (1980) 1163-1171
36. Margrain T.H., Boulton M., Marshall J., and Sliney D.H. Do blue light filters confer protection against age-related macular degeneration?. Prog Retin Eye Res 23 (2004) 523-531
37. Williams T.P., and Howell W.L. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci 24 (1983) 285-287. http://www.iovs.org/cgi/reprint/24/3/285 Accessed April 16, 2000
38. Grimm C., Wenzel A., Hafezi F., Yu S., Redmond T.M., and Reme´ C.E. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. [letter]. Nat Genet 25 (2000) 63-66
39. Grimm C., Wenzel A., Williams T.P., Rol P.O., Hafezi F., and Reme´ C.E. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci 42 (2001) 497-505. http://www.iovs.org/cgi/reprint/42/2/497 Accessed April 16, 2009
40. Reme´ C.E. The dark side of light: rhodopsin and the silent death of vision; the Proctor Lecture. Invest Ophthalmol Vis Sci 46 (2005) 2672-2682. http://www.iovs.org/cgi/reprint/46/8/2672 Accessed April 16, 2009
41. Lawwill T. Three major pathologic processes caused by light in the primate retina: a search for mechanisms. Trans Am Ophthalmol Soc 80 (1982) 517-579. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1312279&blobty pe=pdf Accessed April 16, 2009
42. Ng K.-P., Gugiu B.G., Renganathan K., Davies M.W., Gu X., Crabb J.S., Kim S.R., Ro´z˙anowska M.B., Bonilha V.L., Rayborn M.E., Salomon R.G., Sparrow J.R., Boulton M.E., Hollyfield J.G., and Crabb J.W. Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics 7 (2008) 1397-1405
43. Feeney-Burns L., Berman E.R., and Rothman H. Lipofuscin of human retinal pigment epithelium. Am J Ophthalmol 90 (1980) 783-791
44. Weiter J.J., Delori F.C., Wing G.L., and Fitch K.A. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27 (1986) 145-152. http://www.iovs.org/cgi/reprint/27/2/145 Accessed April 16, 2009
45. Feeney-Burns L., Hilderbrand E.S., and Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci 25 (1984) 195-200. http://www.iovs.org/cgi/reprint/25/2/195.pdf Accessed April 16, 2009
46. Delori F.C., Goger D.G., and Dorey C.K. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42 (2001) 1855-1866. http://www.iovs.org/cgi/reprint/42/8/1855 Accessed April 16, 2009
47. Gaillard E.R., Atherton S.J., Eldred G., and Dillon J. Photophysical studies on human retinal lipofuscin. Photochem Photobiol 61 (1995) 448-453
48. Ro´z˙anowska M., Jarvis-Evans J., Korytowski W., Boulton M.E., Burke J.M., and Sarna T. Blue light-induced reactivity of retinal age pigment; in vitro generation of oxygen-reactive species. J Biol Chem 270 (1995) 18825-18830. http://www.jbc.org/cgi/reprint/270/32/18825 Accessed April 16, 2009
49. Ro´z˙anowska M, Wessels J, Boulton M, Burke JM, J. Rodgers MA, Truscott TG, Sarna T. Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic Biol Med 1998; 24:1107-1112
50. Boulton M., Dontsov A., Jarvis-Evans J., Ostrovsky M., and Svistunenko D. Lipofuscin is a photoinducible free radical generator. J Photochem Photobiol B 19 (1993) 201-204
51. Wihlmark U., Wrigstad A., Roberg K., Nilsson S.E.G., and Brunk U.T. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. Free Radic Biol Med 22 (1997) 1229-1234
52. Shamsi F.A., and Boulton M. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 42 (2001) 3041-3046. http://www.iovs.org/cgi/reprint/42/12/3041 Accessed April 16, 2009
53. Lamb L.E., and Simon J.D. A2E: a component of ocular lipofuscin. Photochem Photobiol 79 (2004) 127-136
54. Sparrow J.R., Vollmer-Snarr H.R., Zhou J., Jang Y.P., Jockusch S., Itagaki Y., and Nakanishi K. A2E-epoxides damage DNA in retinal pigment epithelial cells; vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem 278 (2003) 18207-18213. http://www.jbc.org/cgi/reprint/278/20/18207 Accessed April 16, 2009
55. Sparrow J.R., Zhou J., and Cai B. DNA is a target of the photodynamic effects elicited in A2E-laden RPE by blue-light illumination. Invest Ophthalmol Vis Sci 44 (2003) 2245-2251. http://www.iovs.org/cgi/content/abstract/44/5/2245 Accessed April 16, 2009
56. Sparrow J.R., Zhou J., Ben-Shabat S., Vollmer H., Itagaki Y., and Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 43 (2002) 1222-1227. http://www.iovs.org/cgi/content/full/43/4/1222 Accessed April 16, 2009
57. Sparrow J.R., and Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 42 (2001) 1356-1362. http://www.iovs.org/cgi/content/abstract/42/6/1356 Accessed April 16, 2009
58. Sparrow J.R., Nakanishi K., and Parish C.A. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41 (2000) 1981-1989. http://www.iovs.org/cgi/content/full/41/7/1981 Accessed April 16, 2009
59. Suter M., Reme´ C., Grimm C., Wenzel A., Jäättela M., Esser P., Kociok N., Leist M., and Richter C. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 275 (2000) 39625-39630. http://www.jbc.org/cgi/reprint/275/50/39625 Accessed April 16, 2009
60. Schütt F., Davies S., Kopitz J., Holz F.G., and Boulton M.E. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 41 (2000) 2303-2308. http://www.iovs.org/cgi/reprint/41/8/2303 Accessed April 16, 2009
61. Nilsson S.E.G., Sundelin S.P., Wihlmark U., and Brunk U.T. Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc Ophthalmol 106 (2003) 13-16
62. Kim S.R., Nakanishi K., Itagaki Y., and Sparrow J.R. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 82 (2006) 828-839
63. Sparrow J.R., Fishkin N., Zhou J., Cai B., Jang Y.P., Krane S., Itagaki Y., and Nakanishil K. A2E, a byproduct of the visual cycle. Vision Res 43 (2003) 2983-2990
64. Sparrow J.R., Parish C.A., Hashimoto M., and Nakanishi K. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 40 (1999) 2988-2995. http://www.iovs.org/cgi/reprint/40/12/2988 Accessed April 16, 2009
65. Eldred G.E., and Katz M.L. Fluorophores of the human retinal pigment epithelium: separation and spectral characterization. Exp Eye Res 47 (1988) 71-86
66. Holz F.G., Bellman C., Staudt S., Schütt F., and Völcker H.E. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42 (2001) 1051-1056. http://www.iovs.org/cgi/content/full/42/5/1051 Accessed April 16, 2009
67. Sarks J.P., Sarks S.H., and Killingsworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 2 (1988) 552-577
68. Pautler E.L., Morita M., and Beezley D. Hemoprotein(s) mediate blue light damage in the retinal pigment epithelium. Photochem Photobiol 51 (1990) 599-605
69. Marshall J. Radiation and the ageing eye. Ophthalmic Physiol Opt 5 (1985) 241-263
70. Wenzel A., Grimm C., Marti A., Kueng-Hitz N., Hafezi F., Niemeyer G., and Reme´ C.E. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J Neurosci 20 (2000) 81-88. http://www.jneurosci.org/cgi/reprint/20/1/81 Accessed April 16, 2009
71. Grimm C., Wenzel A., Hafezi F., and Reme´ C.E. Gene expression in the mouse retina: the effect of damaging light. Mol Vis 6 (2000) 252-260. http://www.molvis.org/molvis/v6/a34/v6a34-grimm.pdf Accessed April 16, 2009
72. Klein R., Klein B.E.K., and Cruickshanks K.J. The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18 (1999) 371-389
73. Schmidt S.Y., and Peisch R.D. Melanin concentration in normal human retinal pigment epithelium; regional variation and age-related reduction. Invest Ophthalmol Vis Sci 27 (1986) 1063-1067. http://www.iovs.org/cgi/reprint/27/7/1063 Accessed April 16, 2009
74. Mellerio J. Light effects on the retina. In: Albert D.M., and Jakobiec F.A. (Eds). Principles and Practice of Ophthalmology. Basic Sciences (1994), Saunders, Philadelphia, PA 1326-1345
75. Fariza E., and Castellote M. Clinical light damage by indirect ophthalmoscopy. [letter]. N Engl J Med 329 (1993) 1505-1507 erratum 1994; 330:1320
76. Gorgels T.G.M.F., and van Norren D. Ultraviolet and green light cause different types of damage in rat retina. Invest Ophthalmol Vis Sci 36 (1995) 851-863. http://www.iovs.org/cgi/reprint/36/5/851 Accessed April 16, 2009
77. Koide R., Ueda T.N., Dawson W.W., Hope G.M., Ellis A., Samuelson D., Ueda T., Iwabuchi S., Fukuda S., Matsuishi M., Yasuhara H., Ozawa T., and Armstrong D. [Retinal hazard from blue light emitting diode]. [Japanese]. Nippon Ganka Gakkai Zasshi 105 (2001) 687-695
78. Reme´ C.E., Grimm C., Hafezi F., Wenzel A., and Williams T.P. Apoptosis in the retina: the silent death of vision. News Physiol Sci 15 (2000) 120-125. http://physiologyonline.physiology.org/cgi/reprint/15/3/120 Accessed April 16, 2009
79. van Best J.A., Putting B.J., Oosterhuis J.A., Zweypfenning R.C.V.J., and Vrensen G.F.J.M. Function and morphology of the retinal pigment epithelium after light-induced damage. Microsc Res Tech 36 (1997) 77-88
80. Beatty S., Boulton M., Henson D., Koh H.-H., and Murray I.J. Macular pigment and age related macular degeneration. Br J Ophthalmol 83 (1999) 867-877. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1723114&blobty pe=pdf Accessed April 16, 2009
81. Robson AG, Harding G, van Kuijk FJGM, Pauleikhoff D, Holder GE, Bird AC, Fitzke FW, D Moreland JD. Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception 2005; 34:1029-1034
82. Handelman G.J., Snodderly D.M., Krinsky N.I., Russett M.D., and Adler A.J. Biological control of primate macular pigment; biochemical and densitometric studies. Invest Ophthalmol Vis Sci 32 (1991) 257-267. http://www.iovs.org/cgi/reprint/32/2/257 Accessed April 16, 2009
83. Pease P.L., Adams A.J., and Nuccio E. Optical density of human macular pigment. Vision Res 27 (1987) 705-710
84. Werner J.S., Donnelly S.K., and Kliegl R. Aging and human macular pigment density; appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 27 (1987) 257-268
85. Mainster M.A. Light and macular degeneration: a biophysical and clinical perspective. Eye 1 (1987) 304-310
86. Reme´ C., Reinboth J., Clausen M., and Hafezi F. Light damage revisited: converging evidence, diverging views?. Graefes Arch Clin Exp Ophthalmol 234 (1996) 2-11
87. Hawse P. Blocking the blue. Br J Ophthalmol 90 (2006) 939-940
88. Nilsson S.E. Are there advantages in implanting a yellow IOL to reduce the risk of AMD?. [guest editorial] Acta Ophthalmol Scand 82 (2004) 123-125. http://www3.interscience.wiley.com/cgi-bin/fulltext/118808587/PDFSTART Accessed April 16, 2009
89. Fletcher A.E., Bentham G.C., Agnew M., Young I.S., Augood C., Chakravarthy U., de Jong P.T.V.M., Rahu M., Seland J., Soubrane G., Tomazzoli L., Topouzis F., Vingerling J.R., and Vioque J. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol 126 (2008) 1396-1403
90. Hawkins B.S., Bird A., Klein R., and West S.K. Epidemiology of age-related macular degeneration. Mol Vis 5 (1999) 26. http://www.molvis.org/molvis/v5/a26/v5a26-hawkins.pdf Accessed April 16, 2009
91. Taylor H.R., Mun&tild;oz B., West S., Bressler N.M., Bressler S.B., and Rosenthal F.S. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 88 (1990) 163-173. discussion, 173-178. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1298584&blobty pe=pdf Accessed April 16, 2009
92. Taylor H.R., West S., Mun&tild;oz B., Rosenthal F.S., Bressler S.B., and Bressler N.M. The long-term effects of visible light on the eye. Arch Ophthalmol 110 (1992) 99-104
93. Tomany S.C., Cruickshanks K.J., Klein R., Klein B.E.K., and Knudtson M.D. Sunlight and the 10-year incidence of age-related maculopathy; the Beaver Dam Eye Study. Arch Ophthalmol 122 (2004) 750-757
94. Cruickshanks K.J., Klein R., Klein B.E.K., and Nondahl D.M. Sunlight and the 5-year incidence of early age-related maculopathy; the Beaver Dam Eye Study. Arch Ophthalmol 119 (2001) 246-250
95. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C.W., Klein B.E.K., Hofman A., Jensen S., Wang J.J., and de Jong P.T.V.M. Risk factors for age-related macular degeneration; pooled findings from three continents. Ophthalmology 108 (2001) 697-704
96. Simons K. Artificial light and early-life exposure in age-related macular degeneration and in cataractogenic phototoxicity. [letter]. Arch Ophthalmol 111 (1993) 297-298
97. Blumenkranz M.S., Russell S.R., Robey M.G., Kott-Blumenkranz R., and Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93 (1986) 552-557 discussion by FL Ferris III, 558
98. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110 (1992) 1701-1708
99. Darzins P., Mitchell P., and Heller R.F. Sun exposure and age-related macular degeneration; an Australian case-control study. Ophthalmology 104 (1997) 770-776
100. McCarty C.A., Mukesh B.N., Fu C.L., Mitchell P., Wang J.J., and Taylor H.R. Risk factors for age-related maculopathy; the Visual Impairment Project. Arch Ophthalmol 119 (2001) 1455-1462
101. Delcourt C., Carrie`re I., Ponton-Sanchez A., Fourrey S., Lacroux A., and Papoz L. Light exposure and the risk of age-related macular degeneration; the Pathologies Oculaires Lie´es a` l'Age (POLA) study. Arch Ophthalmol 119 (2001) 1463-1468
102. Hirvelä H., Luukinen H., Läärä E., Sc L., and Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103 (1996) 871-877
103. Wu J., Seregard S., and Algvere P.V. Photochemical damage of the retina. Surv Ophthalmol 51 (2006) 461-481
104. Pollack A., Marcovich A., Bukelman A., and Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 103 (1996) 1546-1554
105. Pollack A., Marcovich A., Bukelman A., Zalish M., and Oliver M. Development of exudative age-related macular degeneration after cataract surgery. Eye 11 (1997) 523-530
106. Klein R., Klein B.E.K., Wong T.Y., Tomany S.C., and Cruickshanks K.J. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy; the Beaver Dam Eye Study. Arch Ophthalmol 120 (2002) 1551-1558
107. Chaine G., Hullo A., Sahel J., Soubrane G., Espinasse-Berrod M., Schutz D., Bourguignon C., Harpey C., Brault Y., Coste M., Moccatti D., and Bourgeois H. Case-control study of the risk factors for age related macular degeneration; France-DMLA Study Group. Br J Ophthalmol 82 (1998) 996-1002. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1722735&blobty pe=pdf Accessed April 16, 2009
108. Wang J.J., Klein R., Smith W., Klein B.E.K., Tomany S., and Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy; pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 110 (2003) 1960-1967
109. Freeman E.E., Munoz B., West S.K., Tielsch J.M., and Schein O.D. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 135 (2003) 849-856
110. Liu I.Y., White L., and LaCroix A.Z. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 79 (1989) 765-769. http://www.ajph.org/cgi/reprint/79/6/765 Accessed April 16, 2009
111. van der Schaft T.L., Mooy C.M., de Bruijn W.C., Mulder P.G., Pameyer J.H., and de Jong P.T. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 78 (1994) 441-445
112. Baatz H., Darawsha R., Ackermann H., Scharioth G.B., de Ortueta D., Pavlidis M., and Hattenbach L.O. Phacoemulsification does not induce neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49 (2008) 1079-1083. http://www.iovs.org/cgi/reprint/49/3/1079 Accessed April 16, 2009
113. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
114. Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., Chen Y., Zhang K., Ambati B.K., Baffi J.Z., and Ambati J. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103 (2006) 2328-2333. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1413680&blobty pe=pdf Accessed April 16, 2009
115. Yates J.R.W., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., and Moore A.T. Complement C3 variant and the risk of age-related macular degeneration; for the Genetic Factors in AMD Study Group. N Engl J Med 357 (2007) 553-561
116. Seddon J.M., Reynolds R., and Rosner B. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. Invest Ophthalmol Vis Sci 50 (2009) 586-591
117. Despriet D.D.G., van Duijn C.M., Oostra B.A., Uitterlinden A.G., Hofman A., Wright A.F., ten Brink J.B., Bakker A., de Jong P.T.V.M., Vingerling J.R., Bergen A.A.B., and Klaver C.C.W. Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116 (2009) 474-480 e2
118. Chappelow A.V., and Kaiser P.K. Neovascular age-related macular degeneration; potential therapies. Drugs 68 (2008) 1029-1036
119. Seddon J.M., Gensler G., Milton R.C., Klein M.L., and Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 291 (2004) 704-710
120. Zaliuniene D., Paunksnis A., Gustiene O., Brazdzionyte J., and Zaliunas R. Pre- and postoperative C-reactive protein levels in patients with cataract and age-related macular degeneration. Eur J Ophthalmol 17 (2007) 919-927
121. Kudo H., Hagiwara S., Saiki K., Hamano K., Ohara F., Hanabusa A., and Ohta Y. [Tinted lens to facilitate color vision after cataract surgery]. [Japanese]. Rinsho Ganka 44 (1990) 473-475
122. Yokoyama Y., Iwamoto H., and Yamanaka A. Blue light-filtering foldable acrylic intraocular lens. J Artif Organs 9 (2006) 71-76
123. Brockmann C., Schulz M., and Laube T. Transmittance characteristics of ultraviolet and blue-light-filtering intraocular lenses. J Cataract Refract Surg 34 (2008) 1161-1166
124. van Norren D., and van de Kraats J. Spectral transmission of intraocular lenses expressed as a virtual age. Br J Ophthalmol 91 (2007) 1374-1375
125. Sliney D.H. Spectral transmission of IOLs expressed as a virtual age. [editorial]. Br J Ophthalmol 91 (2007) 1261-1262
126. Ernest P.H. Light-transmission-spectrum comparison of foldable intraocular lenses. J Cataract Refract Surg 30 (2004) 1755-1758
127. Mainster M.A. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. [perspective]. Br J Ophthalmol 90 (2006) 784-792
128. Pokorny J., and Smith V.C. The Verriest Lecture. How much light reaches the retina?. In: Cavonius C.R. (Ed). Colour Vision Deficiencies XIII; Proceedings of the Thirteenth Symposium of the International Research Group on Colour Vision Deficiencies, held in Pau, France July 27-30, 1995 (1997), Kluwer, Dordrecht, The Netherlands 491-511 (Doc Ophthalmol Proc Ser 59)
129. Nilsson S.E.G., Textorius O., Andersson B.-E., and Swenson B. Clear PMMA versus yellow intraocular lens material. An electrophysiologic study on pigmented rabbits regarding "the blue light hazard.". Prog Clin Biol Res 314 (1989) 539-553
130. Sparrow J.R., Miller A.S., and Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg 30 (2004) 873-878
131. Rezai K.A., Gasyna E., Seagle B.-L.L., Norris Jr. J.R., and Rezaei K.A. AcrySof Natural filter decreases blue light-induced apoptosis in human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 246 (2008) 671-676
132. Miyake K., Ichihashi S., Shibuya Y., Ota I., Miyake S., and Terasaki H. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg 25 (1999) 891-897
133. Yanagi Y., Inoue Y., Iriyama A., and Jang W.-D. Effects of yellow intraocular lenses on light-induced upregulation of vascular endothelial growth factor. J Cataract Refract Surg 32 (2006) 1540-1544
134. Carson D., Margrain T.H., and Patel A. New approach to evaluate retinal protection by intraocular lenses against age-related lipofuscin accumulation-mediated retinal phototoxicity. J Cataract Refract Surg 34 (2008) 1785-1792
135. Cionni R.J., and Tsai J.H. Color perception with AcrySof Natural and AcrySof single-piece intraocular lenses under photopic and mesopic conditions. J Cataract Refract Surg 32 (2006) 236-242
136. Muftuoglu O., Karel F., and Duman R. Effect of a yellow intraocular lens on scotopic vision, glare disability, and blue color perception. J Cataract Refract Surg 33 (2007) 658-666
137. Rodri´guez-Galietero A., Monte´s-Mico´ R., Mun&tild;oz G., and Albarra´n-Diego C. Blue-light filtering intraocular lens in patients with diabetes: contrast sensitivity and chromatic discrimination. J Cataract Refract Surg 31 (2005) 2088-2092
138. Rodri´guez -Galietero A., Monte´s-Mico´ R., Mun&tild;oz G., and Albarra´n-Diego C. Comparison of contrast sensitivity and color discrimination after clear and yellow intraocular lens implantation. J Cataract Refract Surg 31 (2005) 1736-1740
139. Hayashi K., and Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol 90 (2006) 1019-1023
140. Barisˇic´ A., Dekaris I., Gabric´ N., Bosnar D., Lazic´ R., Karaman Martinovic´ Z., and Kondzˇa Krstonijevic´ E. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Coll Antropol 31 suppl 1 (2007) 57-60. http://www.collantropol.hr/_doc/Coll.%20Antropol.%2031%20(2007)%20Suppl. %201:%2057-60.pdf Accessed April 17, 2009
141. ® Natural intraocular lens. Acta Ophthalmol Scand 84 (2006) 92-94
142. Landers J., Tan T.-H., Yuen J., and Liu H. Comparison of visual function following implantation of AcrySof Natural intraocular lenses with conventional intraocular lenses. Clin Exp Ophthalmol 35 (2007) 152-159
143. Falkner-Radler C.I., Benesch T., and Binder S. Blue light-filter intraocular lenses in vitrectomy combined with cataract surgery: results of a randomized controlled clinical trial. Am J Ophthalmol 145 (2008) 499-503
144. Bhattacharjee H., Bhattacharjee K., and Medhi J. Visual performance: comparison of foldable intraocular lenses. J Cataract Refract Surg 32 (2006) 451-455
145. Leibovitch I., Lai T., Porter N., Pietris G., Newland H., and Selva D. Visual outcomes with the yellow intraocular lens. Acta Ophthalmol Scand 84 (2006) 95-99
146. Marshall J., Cionni R.J., Davison J., Ernest P., Lehmann R., Maxwell W.A., and Solomon K. Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens. J Cataract Refract Surg 31 (2005) 2319-2323
147. Wohlfart C., Tschuschnig K., Fellner P., Weiss K., Vidic B., El-Shabrawi Y., and Ardjomand N. Visuelle Funktion mit Blaulichtfilter-IOL. [Visual function with blue light filter IOLs]. Klin Monatsbl Augenheilkd 224 (2007) 23-27
148. Greenstein V.C., Chiosi F., Baker P., Seiple W., Holopigian K., Braunstein R.E., and Sparrow J.R. Scotopic sensitivity and color vision with a blue-light-absorbing intraocular lens. J Cataract Refract Surg 33 (2007) 667-672
149. Raj S.M., Vasavada A.R., and Nanavaty M.A. AcrySof Natural SN60AT versus AcrySof SA60AT intraocular lens in patients with color vision defects. J Cataract Refract Surg 31 (2005) 2324-2328
150. Mester U., Holz F., Kohnen T., Lohmann C., and Tetz M. Intraindividual comparison of a blue-light filter on visual function: AF-1 (UY) versus AF-1 (UV) intraocular lens. J Cataract Refract Surg 34 (2008) 608-615
151. Espindle D., Crawford B., Maxwell A., Rajagopalan K., Barnes R., Harris B., and Hileman K. Quality-of-life improvements in cataract patients with bilateral blue light-filtering intraocular lenses: clinical trial. J Cataract Refract Surg 31 (2005) 1952-1959
152. Shah S.A., and Miller K.M. Explantation of an AcrySof Natural intraocular lens because of a color vision disturbance. Am J Ophthalmol 140 (2005) 941-942
153. Niwa K., Yoshino Y., Okuyama F., and Tokoro T. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt 16 (1996) 297-302
154. Glazer-Hockstein C., and Dunaief J.L. Could blue light-blocking lenses decrease the risk of age-related macular degeneration?. [editorial] Retina 26 (2006) 1-4
155. Norren D.V., and Vos J.J. Spectral transmission of the human ocular media. Vision Res 14 (1974) 1237-1244
156. Griswold M.S., and Stark W.S. Scotopic spectral sensitivity of phakic and aphakic observers extending into the near ultraviolet. Vision Res 32 (1992) 1739-1743
157. Curcio C.A. Photoreceptor topography in ageing and age-related maculopathy. Eye 15 (2001) 376-383
158. Sunness J.S., Rubin G.S., Applegate C.A., Bressler N.M., Marsh M.J., Hawkins B.S., and Haselwood D. Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology 104 (1997) 1677-1691
159. Jackson G.R., Owsley C., and McGwin Jr. G. Aging and dark adaptation. Vision Res 39 (1999) 3975-3982
160. Jackson G.R., Owsley C., and Curcio C.A. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev 1 (2002) 381-396
161. Jackson G.R., and Owsley C. Scotopic sensitivity during adulthood. Vision Res 40 (2000) 2467-2473
162. Aarnisalo E.A. Effects of yellow filter glasses on the results of photopic and scotopic photometry. Am J Ophthalmol 105 (1988) 408-411
163. Schefrin B.E., Tregear S.J., Harvey Jr. L.O., and Werner J.S. Senescent changes in scotopic contrast sensitivity. Vision Res 39 (1999) 3728-3736
164. Jackson G.R., Owsley C., Cordle E.P., and Finley C.D. Aging and scotopic sensitivity. Vision Res 38 (1998) 3655-3662
165. Gunkel R.D., and Gouras P. Changes in scotopic visibility thresholds with age. Arch Ophthalmol 69 (1963) 4-9
166. McMurdo M.E.T., and Gaskell A. Dark adaptation and falls in the elderly. Gerontology 37 (1991) 221-224
167. Curcio C.A., Millican C.L., Allen K.A., and Kalina R.E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci 34 (1993) 3278-3296. http://www.iovs.org/cgi/reprint/34/12/3278.pdf Accessed April 17, 2009
168. Curcio C.A., Owsley C., and Jackson G.R. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci 41 (2000) 2015-2018. http://www.iovs.org/cgi/reprint/41/8/2015.pdf Accessed April 17, 2009
169. Owsley C., Jackson G.R., Cideciyan A.V., Huang Y., Fine S.L., Ho A.C., Maguire M.G., Lolley V., and Jacobson S.G. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) 267-273. http://www.iovs.org/cgi/reprint/41/1/267.pdf Accessed April 18, 2009
170. Owsley C., Jackson G.R., White M., Feist R., and Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology 108 (2001) 1196-1202
171. Charman W.N. Vision and driving - a literature review and commentary. Ophthalmic Physiol Opt 17 (1997) 371-391
172. Klein B.E.K., Klein R., Lee K.E., and Cruickshanks K.J. Associations of performance-based and self-reported measures of visual function. The Beaver Dam Eye Study. Ophthalmic Epidemiol 6 (1999) 49-60
173. Owsley C., and McGwin Jr. G. Vision impairment and driving. Surv Ophthalmol 43 (1999) 535-550
174. Scilley K., Jackson G.R., Cideciyan A.V., Maguire M.G., Jacobson S.G., and Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 109 (2002) 1235-1242
175. Werner J.S. Night vision in the elderly: consequences for seeing through a "blue filtering" intraocular lens. Br J Ophthalmol 89 (2005) 1518-1521
176. Pons A., Delgado D., and Campos J. Determination of the action spectrum of the blue-light hazard for different intraocular lenses. J Opt Soc Am A Opt Image Sci Vis 24 (2007) 1545-1550
177. Mainster M.A., and Sparrow J.R. How much blue light should an IOL transmit?. [perspective]. Br J Ophthalmol 87 (2003) 1523-1529
178. Schwiegerling J. Blue-light-absorbing lenses and their effect on scotopic vision. J Cataract Refract Surg 32 (2006) 141-144
179. Mainster M.A. Blue-blocking intraocular lenses and pseudophakic scotopic sensitivity. [letter]. J Cataract Refract Surg 32 (2006) 1403-1404 reply by J Schwiegerling, 1404-1405; editor's note, 1406
180. Green C.B., and Besharse J.C. Retinal circadian clocks and control of retinal physiology. J Biol Rhythms 19 (2004) 91-102
181. Hankins M.W., and Lucas R.J. The primary visual pathway in humans is regulated according to long-term light exposure through the action of a nonclassical photopigment. Curr Biol 12 (2002) 191-198. Available at: http://download.cell.com/current-biology/pdf/PIIS0960982202006590.pdf?in termediate=true Accessed April 18, 2008
182. Li F., Cao W., and Anderson R.E. Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light. Exp Eye Res 73 (2001) 569-577
183. Tosini G., and Fukuhara C. The mammalian retina as a clock. Cell Tissue Res 309 (2002) 119-126
184. Hankins M.W., Peirson S.N., and Foster R.G. Melanopsin: an exciting photopigment. Trends Neurosci 31 (2008) 27-36
185. Foster R.G., and Hankins M.W. Circadian vision. Curr Biol 17 (2007) R746-R751
186. Wyszecki G., and Stiles W.S. Color Science; Concepts and Methods, Quantitative Data and Formulae, 2nd ed (1982), John Wiley & Sons, New York, NY
187. Govardovskii V.I., Fyhrquist N., Reuter T., Kuzmin D.G., and Donner K. In search of the visual pigment template. Vis Neurosci 17 (2000) 509-528
188. Hattar S., Lucas R.J., Mrosovsky N., Thompson S., Douglas R.H., Hankins M.W., Lem J., Biel M., Hofmann F., Foster R.G., and Yau K.-W. Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. [letter]. Nature 424 (2003) 76-81
189. Dacey D.M., Liao H.-W., Peterson B.B., Robinson F.R., Smith V.C., Pokorny J., Yau K.-W., and Gamlin P.D. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. [letter]. Nature 433 (2005) 749-754
190. Zaidi F.H., Hull J.T., Peirson S.N., Wulff K., Aeschbach D., Gooley J.J., Brainard G.C., Gregory-Evans K., Rizzo III J.F., Czeisler C.A., Foster R.G., Moseley M.J., and Lockley S.W. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol 17 (2007) 2122-2128. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2151130&blobty pe=pdf Accessed April 18, 2008
191. Hankins M.W., and Foster R.G. A novel light sensing pathway in the eye: conserved features of inner retinal photoreception in rodents, man and teleost fish. In: Briggs W.R., and Spudich J.L. (Eds). Handbook of Photosensory Receptors (2005), Wiley-VCH, Weinheim, Germany 93-119
192. Ruby N.F., Brennan T.J., Xie X., Cao V., Franken P., Heller H.C., and O'Hara B.F. Role of melanopsin in circadian responses to light. Science 298 (2002) 2211-2213
193. Panda S., Sato T.K., Castrucci A.M., Rollag M.D., DeGrip W.J., Hogenesch J.B., Provencio I., and Kay S.A. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 298 (2002) 2213-2216
194. Lucas R.J., Hattar S., Takao M., Berson D.M., Foster R.G., and Yau K.W. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 299 (2003) 245-247
195. Mrosovsky N. Contribution of classic photoreceptors to entrainment. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 189 (2003) 69-73
196. Belenky M.A., Smeraski C.A., Provencio I., Sollars P.J., and Pickard G.E. Melanopsin retinal ganglion cells receive bipolar and amacrine cell synapses. J Comp Neurol 460 (2003) 380-393
197. Thompson S., Foster R.G., Stone E.M., Sheffield V.C., and Mrosovsky N. Classical and melanopsin photoreception in irradiance detection: negative masking of locomotor activity by light. Eur J Neurosci 27 (2008) 1973-1979
198. Brainard G.C., Sliney D., Hanifin J.P., Glickman G., Byrne B., Greeson J.M., Jasser S., Gerner E., and Rollag M.D. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms 23 (2008) 379-386
199. Dkhissi-Benyahya O., Gronfier C., De Vanssay W., Flamant F., and Cooper H.M. Modeling the role of mid-wavelength cones in circadian responses to light. Neuron 53 (2007) 677-687. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1950159&blobty pe=pdf Accessed April 18, 2009
200. Thapan K., Arendt J., and Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol (Lond) 535 (2001) 261-267. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2278766&blobty pe=pdf Accessed April 18, 2009
201. Paul M.A., Miller J.C., Gray G., Buick F., Blazeski S., and Arendt J. Circadian phase delay induced by phototherapeutic devices. Aviat Space Environ Med 78 (2007) 645-652
202. Zeitzer J.M., Dijk D.-J., Kronauer R.E., Brown E.N., and Czeisler C.A. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526 (2000) 695-702
203. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.A., and Markey S.P. Light suppresses melatonin secretion in humans. Science 210 (1980) 1267-1269
204. Boyce P., and Kennaway D.J. Effects of light on melatonin production. Biol Psychiatry 22 (1987) 473-478
205. McIntyre I.M., Norman T.R., Burrows G.D., and Armstrong S.M. Human melatonin suppression by light is intensity dependent. J Pineal Res 6 (1989) 149-156
206. Middleton B., Stone B.M., and Arendt J. Human circadian phase in 12:12 h, 200: <8 lux and 1000: <8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett 329 (2002) 41-44
207. Dijk D.-J., Neri D.F., Wyatt J.K., Ronda J.M., Riel E., Ritz-De Cecco A., Hughes R.J., Elliott A.R., Prisk G.K., West J.B., and Czeisler C.A. Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol 281 (2001) R1647-R1664. http://ajpregu.physiology.org/cgi/reprint/281/5/R1647 Accessed April 18, 2009
208. Turner P.L., and Mainster M.A. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol 92 (2008) 1439-1444
209. Brainard G.C., Hanifin J.P., Rollag M.D., Greeson J., Byrne B., Glickman G., Gerner E., and Sanford B. Human melatonin regulation is not mediated by the three cone photopic visual system. J Clin Endocrinol Metab 86 (2001) 433-436. http://jcem.endojournals.org/cgi/reprint/86/1/433 Accessed April 18, 2009
210. Lack L.C., and Wright H.R. Clinical management of delayed sleep phase disorder. Behav Sleep Med 5 (2007) 57-76
211. Hofman M.A., and Swaab D.F. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 5 (2006) 33-51. http://cfx-jrs.ap-hop-paris.fr/geronto/cours/bibliographie/Livingbythecl ock2006.pdf Accessed April 18, 2009
212. Foster R.G., and Wulff K. The rhythm of rest and excess. Nat Rev Neurosci 6 (2005) 407-414
213. Van Someren E.J.W., Riemersma R.F., and Swaab D.F. Functional plasticity of the circadian timing system in old age: light exposure. Prog Brain Res 138 (2002) 205-231
214. Van Someren E.J.W., Swaab D.F., Colenda C.C., Cohen W., McCall W.V., and Rosenquist P.B. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 16 (1999) 505-518
215. Riemersma-van der Lek R.F., Swaab D.F., Twisk J., Hol E.M., Hoogendijk W.J., and Van Someren E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities; a randomized controlled trial. JAMA 299 (2008) 2642-2655. Available at: http://jama.ama-assn.org/cgi/reprint/299/22/2642?maxtoshow=&HITS=10& amp;hits=10&RESULTFORMAT=&searchid=1&FIRSTINDEX=40&resou rcetype=HWFIG Accessed April 18, 2009
216. Asplund R., and Ejdervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr 35 (2002) 179-187
217. Asplund R., and Ejdervik Lindblad B. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr 38 (2004) 69-75
218. Sloane P.D., Williams C.S., Mitchell C.M., Preisser J.S., Wood W., Barrick A.L., Hickman S.E., Gill K.S., Connell B.R., Edinger J., and Zimmerman S. High-intensity environmental light in dementia: effect on sleep and activity. J Am Geriatr Soc 55 (2007) 1524-1533
219. Shochat T., Martin J., Marler M., and Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 9 (2000) 373-379. http://www3.interscience.wiley.com/cgi-bin/fulltext/120714155/PDFSTART Accessed April 18, 2009
220. Charman W.N. Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt 23 (2003) 181-187
221. Burns E.R. Biological time and in vivo research: a field guide to pitfalls. Anat Rec 261 (2000) 141-152. http://www3.interscience.wiley.com/cgi-bin/fulltext/72515480/PDFSTART Accessed April 18, 2009
222. Augustin A.J. The physiology of scotopic vision, contrast vision, color vision, and circadian rhythmicity. Can these parameters be influenced by blue-light-filter lenses?. Retina 28 (2008) 1179-1187
223. Meyers S.M., Ostrovsky M.A., and Bonner R.F. A model of spectral filtering to reduce photochemical damage in age-related macular degeneration. Trans Am Ophthalmol Soc 102 (2004) 83-93. http://www.aosonline.org/xactions/2004/1545-6110_v102_p083.pdf Accessed April 18, 2009
224. Nations U. Department of Economic and Social Affairs. Population Division. World Population Projections to 2150 (1998), United Nations, New York, NY